BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20392911)

  • 1. Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia.
    Nakamura A; Sugimoto Y; Ohishi K; Sugawara Y; Fujieda A; Monma F; Suzuki K; Masuya M; Nakase K; Matsushima Y; Wada H; Katayama N; Nobori T
    J Clin Microbiol; 2010 Jun; 48(6):2030-6. PubMed ID: 20392911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia.
    von Lilienfeld-Toal M; Lehmann LE; Raadts AD; Hahn-Ast C; Orlopp KS; Marklein G; Purr I; Cook G; Hoeft A; Glasmacher A; Stüber F
    J Clin Microbiol; 2009 Aug; 47(8):2405-10. PubMed ID: 19571034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia.
    Lamoth F; Jaton K; Prod'hom G; Senn L; Bille J; Calandra T; Marchetti O
    J Clin Microbiol; 2010 Oct; 48(10):3510-6. PubMed ID: 20720024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nested multiplex PCR for detection of bacterial and fungal blood stream infections in patients with hematological malignancies.
    Hassanin NAAH; Abdallah NMA; Abdalla NEH; Kholeif L; Shabban M
    J Infect Dev Ctries; 2020 May; 14(5):511-518. PubMed ID: 32525838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of infections during intensive treatment of hematologic malignancies.
    Maschmeyer G; Hiddemann W; Link H; Cornely OA; Buchheidt D; Glass B; Adam D
    Ann Hematol; 1997; 75(1-2):9-16. PubMed ID: 9322678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of bacteria and fungi in blood of patients with febrile neutropenia by real-time PCR with universal primers and probes.
    Teranishi H; Ohzono N; Inamura N; Kato A; Wakabayashi T; Akaike H; Terada K; Ouchi K
    J Infect Chemother; 2015 Mar; 21(3):189-93. PubMed ID: 25497674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia.
    Sakaguchi S; Saito M; Tsuji H; Asahara T; Takata O; Fujimura J; Nagata S; Nomoto K; Shimizu T
    J Clin Microbiol; 2010 May; 48(5):1624-8. PubMed ID: 20351213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies.
    Nenova IS; Goranov SE; Mateva NG; Ananoshtev NH
    Folia Med (Plovdiv); 2003; 45(1):13-9. PubMed ID: 12943062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia.
    Paholcsek M; Fidler G; Konya J; Rejto L; Mehes G; Bukta E; Loeffler J; Biro S
    BMC Infect Dis; 2015 Jul; 15():251. PubMed ID: 26126706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations.
    de Lalla F
    Drugs; 1997 May; 53(5):789-804. PubMed ID: 9129866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current spectrum of infection in cancer patients with chemotherapy related neutropenia.
    Nesher L; Rolston KV
    Infection; 2014 Feb; 42(1):5-13. PubMed ID: 23975584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinational approach using in situ hybridization targeting 23S ribosomal RNA genes and blood cultures for bacterial identification in patients with neutropenia and fever.
    Koh H; Aimoto M; Matsuhisa A; Inoue S; Katayama T; Okamura H; Yoshimura T; Koh S; Nanno S; Nishimoto M; Nakashima Y; Hirose A; Nakamae M; Nakane T; Hino M; Nakamae H
    J Infect Chemother; 2016 Oct; 22(10):697-703. PubMed ID: 27581389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients.
    Bothra M; Seth R; Kapil A; Dwivedi SN; Bhatnagar S; Xess I
    Indian J Pediatr; 2013 Apr; 80(4):297-302. PubMed ID: 23255077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
    Ritchie S; Palmer S; Ellis-Pegler R
    Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
    Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M
    Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.